Pass through the peptide compounds and peptide conjugate of receptor-mediated regimen chemotherapy cancer

• 收藏
• 分享

专利权人:

TRANSFERT PLUS S.E.C.

发明人:

ALAIN LAROCQUE,BORHANE ANNABI,CYNDIA CHARFI,JEAN-CHRISTOPHE CURRIE,MICHEL DEMEULE,RICHARD BÉLIVEAU

申请号：

BR112018010535

公开号：

BR112018010535A2

申请日:

2016.11.24

申请国别(地区):

BR

年份:

2018

代理人:

摘要：

This disclosure relates to be used for treating cancer and increase the peptide compounds and conjugated compound, preparation process, method and their purposes of the cell internalizing of peptide compounds.The peptide compounds are selected from:Such as SEQ ID NO:GVRAKAGVRNMFKSESY shown in 9;Such as SEQ ID NO:GVRAKAGVRN shown in 10 (Nle) FKSESY;With such as SEQ ID NO:YKSLRRKAPRWDAPLRDPALRQLL shown in 11;And wherein at least one blocking group and/or at least one labelled reagent are connect with the peptide compounds.

来源网站：

中国工程科技知识中心

来源网址：

http://www.ckcest.cn/home/